Kisspeptin
Kisspeptin, explained.
Kisspeptin sits at the very top of the body's reproductive hormone cascade and is one of the most-studied peptides in research on libido and fertility. This page is a neutral, science-first overview of what kisspeptin is, how it is thought to work, and where it sits legally — educational only, not medical advice.
Educational only — not medical advice. Consult a qualified licensed provider.
Kisspeptin is a neuropeptide encoded by the KISS1 gene that acts on the KISS1R receptor on hypothalamic GnRH neurons. By triggering GnRH release, it drives downstream LH and FSH secretion, making it the master upstream switch of the reproductive hormone axis. Human research forms include kisspeptin-54 and kisspeptin-10. It is not approved by the FDA for any use.
What kisspeptin is
Kisspeptin is a family of neuropeptides produced from the KISS1 gene and signaling through the KISS1R (formerly GPR54) receptor. The name has nothing to do with kissing — it was discovered in Hershey, Pennsylvania, home of the chocolate kiss, and the gene was tagged accordingly. Biologically it's more important than the name suggests: loss-of-function mutations in KISS1R cause failure to enter puberty, which is how researchers came to understand that kisspeptin sits at the very top of the hypothalamic-pituitary-gonadal (HPG) axis. Several lengths circulate in humans — the full kisspeptin-54 and shorter fragments like kisspeptin-10 and kisspeptin-13 — all of which share the active C-terminal end and bind the same receptor. In clinical research, kisspeptin-54 and kisspeptin-10 are the forms that have been infused into people. It is a signaling peptide, not a hormone replacement, an anabolic, or a steroid.
How kisspeptin is thought to work
Reproductive hormone release starts in the hypothalamus, where GnRH (gonadotropin-releasing hormone) neurons fire in pulses. Kisspeptin neurons sit just upstream of them: when kisspeptin binds KISS1R on GnRH neurons, it triggers GnRH release, which then signals the pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH) — the gonadotropins that act on the testes and ovaries. In short, kisspeptin is the upstream switch and GnRH is the relay. This is why it is studied so heavily: in research it can stimulate the natural pulsatile rhythm of the axis rather than overriding it the way continuous GnRH agonists do. Human studies show the LH response is sexually dimorphic (men and women respond differently), and fMRI work has reported that kisspeptin also modulates limbic brain regions tied to sexual and emotional processing — a mechanism studied centrally, not only at the level of downstream hormones.
Areas of research interest
- Libido and sexual response — randomized fMRI trials in men and women with hypoactive sexual desire disorder (HSDD) have studied whether kisspeptin modulates sexual-processing brain regions; these are early research findings, not an approved treatment.
- Reproductive hormone signaling — studied as a probe of LH/FSH release and HPG-axis function in research settings.
- Fertility and ovulation triggering — investigated as an alternative to hCG/GnRH for triggering egg maturation in IVF, including research into ovarian hyperstimulation risk (investigational).
- Hypothalamic amenorrhea and conditions of low energy balance — studied in the context of reproductive signaling where the axis has gone quiet (research only).
- Hyperprolactinemia — proof-of-concept research has examined kisspeptin's effect on LH pulses suppressed by high prolactin.
- Diagnostic and mechanistic studies of puberty, anorexia, and PCOS, where kisspeptin signaling is altered.
Side effects & safety
Most published human data on kisspeptin comes from short, single-session infusions administered intravenously or subcutaneously under medical supervision in academic studies. Reported observations in that setting include transient flushing and a sensation of warmth, which investigators have linked to its mechanism. Important limits to keep in mind: the long-term safety of repeated administration outside a supervised study is essentially unstudied, and material described as research-grade kisspeptin-10 is not the pharmaceutical-grade peptide used in those trials, so its identity, purity, sterility, and actual content are unknown. Reproductive and hormone signaling is a clinical matter; anyone pregnant, trying to conceive, on reproductive or fertility treatment, or with a hormone-sensitive condition should consult a qualified licensed provider. This page is educational and is not medical advice.
Kisspeptin-54 vs kisspeptin-10
| Kisspeptin-54 | Kisspeptin-10 | |
|---|---|---|
| Length | 54 amino acids (full peptide) | 10 amino acids (C-terminal fragment) |
| Receptor | KISS1R (GPR54) | KISS1R (GPR54) |
| Half-life | Longer; favored for sustained infusion | Shorter; rapid, briefer action |
| Most-studied route | IV / SC infusion in clinical trials | IV bolus and intranasal in research |
| Typical research context | HSDD, fertility triggering, HPG-axis studies | Acute LH-response probes, intranasal studies |
| Status | Investigational, not FDA-approved | Investigational / research-chemical, not FDA-approved |
Legal & regulatory status
Kisspeptin is not approved by the FDA for any use and remains investigational. Kisspeptin-10 was flagged by the FDA as a compounding bulk substance with safety concerns (Category 2) rather than cleared for pharmacy compounding. Anything sold to consumers is research-only material with no regulatory oversight of identity, purity, sterility, or actual content, and is typically labeled 'for research use only, not for human consumption.' This page is educational and is not medical advice. For anything involving fertility or hormone health, a qualified licensed provider is the right venue — not a research-chemical site.
Frequently asked
Is kisspeptin a steroid or a hormone?+
Neither. Kisspeptin is a signaling neuropeptide that acts upstream in the brain to trigger GnRH release, which in turn drives the body's own LH, FSH, and downstream sex-hormone production. It is studied as a switch on the body's natural reproductive cascade rather than a replacement for a hormone like testosterone or estrogen, and it is not an anabolic steroid.
Is kisspeptin FDA approved?+
No. Kisspeptin is not FDA-approved for any use and remains investigational. Kisspeptin-10 was also flagged by the FDA as a compounding bulk substance with safety concerns (Category 2) rather than cleared for pharmacy compounding, and its status is still under review. Anything sold to consumers is research-only material not approved for human use — be clear-eyed about that legal and quality status.
What is kisspeptin studied for in fertility?+
In research, kisspeptin has been studied as a trigger for egg maturation during IVF — including investigation of ovarian hyperstimulation syndrome risk relative to hCG or GnRH agonists — and in the context of restoring reproductive signaling in conditions like hypothalamic amenorrhea. These are investigational findings; any fertility-related decision belongs with a reproductive specialist, not self-experimentation.
What does the research say about kisspeptin and libido?+
Randomized, placebo-controlled fMRI studies in men and women with hypoactive sexual desire disorder have examined whether kisspeptin influences brain regions associated with sexual and emotional processing. These are small, early-stage research investigations — an area of scientific interest, not an approved or established treatment for low libido.
Everything peptides, made easy.
Join PepEasy and get the tools, the knowledge, and the care — in one place.